Protecting Those Who Protect Us: PPSS Group Introduces Slash Proof Clothing
20.4.2017 17:00:00 EEST | Business Wire | Press release
SlashPRO™ Slash Proof Clothing is designed to protect prison and corrections officers, homeland security professionals, those working within law enforcement, border control, immigration and everyone in the private security sector.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170420005615/en/
SlashPRO Slash Resistant Clothing can effectively help protect professionals working within hostile environments from laceration, subsequent rapid blood loss and death! (Photo: Business Wire)
Slashing dangers are relatively frequent for these men and women. It is an occupational risk they face on a daily basis. Subsequent rapid blood loss often leads to fatality, and it is the SlashPRO™ mission to protect professionals at risk, with a range of easy-to-wear, slash-resistant clothing.
The SlashPRO™ clothing range provides extensive protection to body and limbs, also covering the five main arterial areas: Radial (wrist), Brachial (along bicep), Carotid (throat), Axillary (beneath arm pit) and Femoral (thigh region).
Rusty Keeble, CEO of U.S. based ‘The Gang Enforcement Company’ commented: “The slash-resistant combat shirt is one bad ass piece of officer protection wear. The design is comfortable, professional-looking and allows you to move freely and naturally".
Robert Kaiser, CEO of PPSS Group is excited and pleased: “I am absolutely thrilled and genuinely happy knowing SlashPRO™ Clothing has finally been launched.”
“Following several reported incidents, which have seen officers around the world being slashed and suffering rapid blood loss, my team and I felt strongly that slash-resistant clothing can prevent such injuries and ultimately save lives”.
One of the most recent reported incidents took place at the Maghaberry Jail in Northern Ireland in May this year. This assault saw a female prison officer being slashed across her face. Full details can be found on the Irish News website: click here
Orders for SlashPRO™ clothing have been taken from highly regarded professionals, privately owned companies and government agencies worldwide, of which many have provided excellent testimonial to the quality of the clothing range.
Please visit www.slash-pro.com to view the full catalogue of slash- and cut-resistant clothing, as well as testimonials and a filmed product demonstration.
About Us:
PPSS Group is a UK headquartered (and also U.S. registered) firm specialising in the design, development and manufacturing of high performance body armour and protective clothing - offering protection from firearms, edged weapons, hypodermic needles as well as blunt force trauma and human bites.
Please follow us on social media:
- Facebook click here
- Twitter click here
- LinkedIn click here
- Instagram click here
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170420005615/en/
Contact information
PPSS Group
Becky Foster
bf@ppss-group.com
+44(0)8455193953
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 23:04:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10.0 billion, or approximately $8.8 billion net of estimated cash acquired. The transaction was unanimously approved by both the Vertex and Crinetics Boards of Directors and is anticipated to close in the third quarter of 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706876183/en/ Crinetics’ marketed medicine, PALSONIFY® (paltusotine), received approval from the U.S. Food and Drug Administration (FDA) in September 2025. PALSONIFY was recently approved by the European Medicines Agency (EMA) a
Ciauru Wins the Second Edition of the Reply AI Music Contest, the International Competition Dedicated to Experimentation Across AI, Music and Live Performance6.7.2026 21:30:00 EEST | Press release
The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706007611/en/ The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival First place went to Ciauru, the stage name of Simone Privitera, an Italian multi-platinum DJ and producer who integrates artificial intelligence tools into a musical practice rooted in the contemporary electronic scene. With a career that has seen him collaborate wit
Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 20266.7.2026 16:00:00 EEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced it will report earnings after market close on July 30, 2026. The company will host a conference call and webcast on that date to discuss the second quarter 2026 results and the second half 2026 outlook at 5:00 p.m. Eastern / 2:00 p.m. Pacific time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706560476/en/ Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 2026 A live webcast of the event will be available on Rimini Street’s Investor Relations site via the Rimini Street IR events link and directly via the webcast link. Dial-in participants can access the conference by dialing 1-800-836-8184. A replay of the webcast will be available for one year following the event. About Rimini Street, Inc. Rimini Street, Inc. (Nasda
Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe6.7.2026 16:00:00 EEST | Press release
Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for intravenous (IV) nivolumab biosimilar referencing one of the world’s most widely used cancer immunotherapies to widen patient access across Europe. Nivolumab helped usher in the era of immuno-oncology, transforming the outlook for patients with cancers such as melanoma and lung cancer. As the originator approaches loss of exclusivity in Europe, this partnership aims to put a high-quality, EU-GMP-manufactured nivolumab biosimilar within reach of more patients, reducing healthcare burden. In 2025, Nivolumab recorded sales of approximately USD4.1 billion (Source: IQVIA/IMS) Europe — underscoring the scale of the opportunity. Under the agreement, Orion will hold the exclusive rights to register, market, distribute and sell the nivolumab biosimilar across Europe. Shilpa Biologicals will lead product developm
No-Loss Trading Platform UpsideOnly Surpasses 100,000 Users Within Weeks of Launch6.7.2026 15:48:00 EEST | Press release
Perpetuals.com Ltd (Nasdaq: PDC), today announced that UpsideOnly, its risk-free trading and market prediction platform, has seen a surge in new user sign-ups, surpassing the important milestone of 100,000 traders within weeks of its launch on May 19. UpsideOnly lets users make predictions about where global equity, commodity, forex, and crypto markets are heading without ever placing a real trade themselves. Perpetuals uses its own capital to trade on the strongest signals identified by its proprietary AI. If those trades win, Perpetuals shares the profits with the users who helped generate the signal. If the trade doesn’t make money, users lose nothing. Reaching 100,000 users so quickly after launching is a reflection of the enormous demand for a platform that flips the traditional retail trading model on its head, with early platform data showing strong engagement across asset classes, geographies and user activity: Users from more than 180 different countries $38.4 billion in cumul
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom